Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role of T channels in cardiovascular function

K Hermsmeyer1

  • 1Oregon Regional Primate Research Center, and Department of Medicine, Oregon Health Sciences University, Beaverton 97006, USA.

Cardiology
|May 7, 1998
PubMed
Summary

A new drug, mibefradil, selectively blocks transient (T)-type calcium channels, offering cardiovascular protection. This T-type calcium channel blockade improves heart function and survival in heart failure models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen.

American journal of obstetrics and gynecology·1999
Same author

In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·1998
Same author

Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys.

The Journal of clinical endocrinology and metabolism·1998
Same author

Ca2+ release mechanism of primate drug-induced coronary vasospasm.

The American journal of physiology·1997
Same author

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm.

Nature medicine·1997

Area of Science:

  • Cardiovascular Pharmacology
  • Ion Channel Biology

Background:

  • Two types of calcium (Ca2+) channels exist in the cardiovascular system.
  • T-type Ca2+ channels' role remained unclear due to a lack of selective blockers.

Purpose of the Study:

  • To investigate the cardiovascular effects of a novel T-type Ca2+ channel antagonist.
  • To elucidate the significance of T-type Ca2+ channel signaling in cardiovascular health and disease.

Main Methods:

  • Utilized mibefradil, a selective tetralol Ca2+ antagonist, to block T-type Ca2+ channels.
  • Evaluated effects on vasodilation, cardiac function, and animal models of hypertension and heart failure.

Main Results:

  • Mibefradil demonstrated vascular selectivity and inhibited left ventricular thickening.
  • Selective T-type Ca2+ channel blockade reduced heart rate, subendothelial proliferation, and improved survival in disease models.
  • Mibefradil increased coronary blood flow and improved subendocardial perfusion without increasing myocardial oxygen consumption.

Conclusions:

  • T-type Ca2+ channel blockade with mibefradil offers significant cardiovascular protective benefits.
  • This approach normalizes pathophysiological factors, improves heart failure, and provides long-term protection.
  • Benefits are observed even in the presence of severe heart failure conditions.

Related Experiment Videos